根据2013年欧洲人类生殖与胚胎学会与欧洲妇科内镜学会分类,先天性子宫异常女性的产科并发症:系统综述与Meta分析
本系统综述与Meta分析纳入47项研究,基于2013年ESHRE/ESGE分类评估先天性子宫异常女性的产科并发症风险。与无异常女性相比,先天性子宫异常与早产、宫颈机能不全、胎膜早破、胎位异常、胎儿生长受限、胎盘早剥、前置胎盘、胎盘滞留及剖宫产风险升高相关。U2(纵隔子宫)、U3(双角子宫)、U4(单角子宫)亦独立与早产、胎位异常、剖宫产及胎盘早剥相关。
要点
- 先天性子宫异常与早产风险升高相关(OR 3.89,95% CI 3.11-4.88)。
- 先天性子宫异常与胎位异常风险升高相关(OR 11.11,95% CI 5.74-21.49)。
- U2、U3、U4类子宫异常均独立与早产、胎位异常、剖宫产及胎盘早剥相关。
核心结论
- 先天性子宫异常在所有 examined 的ESHRE和ESGE分类中均与产科并发症相关。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、Scopus和ClinicalTrials.gov自建库至2021年1月,并筛选纳入文献及既往系统综述的参考文献列表。
- 纳入调查任何已知类型先天性子宫异常女性产科结局的比较性和非比较性研究,由两名评价者独立进行筛选和 eligibility 评估。
- 共纳入47项研究,采用Newcastle-Ottawa质量评估量表评估纳入比较性研究的质量。
- 使用RevMan和Stata采用随机效应模型计算比值比(OR)、各产科结局的合并比例及95% CI。
主要发现
- 与无子宫异常女性相比,先天性子宫异常与早产风险升高相关(OR 3.89,95% CI 3.11-4.88)。
- 与无子宫异常女性相比,先天性子宫异常与宫颈机能不全风险升高相关(OR 15.13,95% CI 11.74-19.50)。
- 与无子宫异常女性相比,先天性子宫异常与胎膜早破风险升高相关(OR 2.48,95% CI 1.38-4.48)。
- 与无子宫异常女性相比,先天性子宫异常与胎位异常风险升高相关(OR 11.11,95% CI 5.74-21.49)。
- 与无子宫异常女性相比,先天性子宫异常与胎儿生长受限风险升高相关(OR 3.75,95% CI 1.88-7.46)。
关键数值与推荐
- 先天性子宫异常女性合并估计风险:早产25%,胎位异常40%,剖宫产64%,胎膜早破12%,胎儿生长受限15%,胎盘早剥4%,子痫前期5%,宫颈机能不全13%,前置胎盘2%。
- 与无子宫异常女性相比,先天性子宫异常与胎盘早剥风险升高相关(OR 5.21,95% CI 3.34-8.13)。
- 与无子宫异常女性相比,先天性子宫异常与前置胎盘风险升高相关(OR 4.00,95% CI 1.87-8.56)。
- 与无子宫异常女性相比,先天性子宫异常与胎盘滞留风险升高相关(OR 1.71,95% CI 1.16-2.52)。
- 与无子宫异常女性相比,先天性子宫异常与剖宫产风险升高相关(OR 4.52,95% CI 2.19-9.31)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the risk for obstetric complications in women with congenital uterine anomalies and the risk in each main class of uterine anomaly (U2 [septate], U3 [bicorporeal], U4 [hemi-uterus]), based on the 2013 classification by the ESHRE (European Society of Human Reproduction and Embryology) and the ESGE (European Society for Gynaecological Endoscopy). DATA SOURCES: MEDLINE, Scopus, and ClinicalTrials.gov were searched from inception until January 2021. The reference list of all included articles and previous systematic reviews were also screened to identify potential additional articles. METHODS OF STUDY SELECTION: Comparative and noncomparative studies that investigated the obstetric outcomes of women with any type of known congenital uterine anomaly were considered eligible for inclusion. Screening and eligibility assessment was performed independently by two reviewers. TABULATION, INTEGRATION, AND RESULTS: Forty-seven studies were included. The quality of included comparative studies was assessed using the Newcastle-Ottawa Quality Assessment Scale. Odds ratios (ORs), pooled proportions of each obstetric outcome, and 95% CIs were calculated in RevMan and Stata accordingly, using random effects models. Congenital uterine anomalies were associated with increased risk of preterm birth (OR 3.89, 95% CI 3.11-4.88); cervical insufficiency (OR 15.13, 95% CI 11.74-19.50); prelabor rupture of membranes (OR 2.48, 95% CI 1.38-4.48); fetal malpresentation (OR 11.11, 95% CI 5.74-21.49); fetal growth restriction (OR 3.75, 95% CI 1.88-7.46); placental abruption (OR 5.21, 95% CI 3.34-8.13); placenta previa (OR 4.00, 95% CI 1.87-8.56); placental retention (OR 1.71, 95% CI 1.16-2.52); and cesarean birth (OR 4.52, 95% CI 2.19-9.31); when compared with those without anomalies. Pooled estimated risks were 25% for preterm birth, 40% for fetal malpresentation, 64% for cesarean birth, 12% for prelabor rupture of membranes, 15% for fetal growth restriction, 4% for placental abruption, 5% for preeclampsia, 13% for cervical insufficiency, and 2% for placenta previa. Classes U2 (septate), U3 (bicorporeal), and U4 (hemi-uterus) were also associated independently with preterm birth, fetal malpresentation, cesarean birth, and placental abruption. CONCLUSION: Congenital uterine anomalies are associated with obstetric complications across all examined ESHRE and ESGE classifications. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42021244487.
引用
- Panagiotopoulos M, Tseke P, Michala L, et al. Obstetric Complications in Women With Congenital Uterine Anomalies According to the 2013 European Society of Human Reproduction and Embryology and the European Society for Gynaecological Endoscopy Classification: A Systematic Review and Meta-analysis. Obstet Gynecol. 2022. PMID: 34856567. doi:10.1097/AOG.0000000000004627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。